| 1 | [SID103349923] | Unspecified | IC50 | 25 | Inhibition of 50% of the integrase-mediated catalysis of the V1/V2 substrate [AID226214, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | IC50 | 25 [uM] | | BioAssay | Inhibition of 50% of the integrase-mediated catalysis of the V1/V2 substrate | | AID | 226214 | | BioAssay type | Literature | | Target | | | PubMed | 12166940 | | Data Table |  |
|
| 2 | [SID103349923] | Unspecified | IC50 | 25 | Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate [AID226216, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | IC50 | 25 [uM] | | BioAssay | Inhibition of 50% of the integrase-mediated catalysis of the Y-oligo substrate | | AID | 226216 | | BioAssay type | Literature | | Target | | | PubMed | 12166940 | | Data Table |  |
|
| 3 | [SID103349923] | Unspecified | ED50 | 1000 | Inhibition of HIV replication by 50%. [AID82726, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | ED50 | 1000 [uM] | | BioAssay | Inhibition of HIV replication by 50%. | | AID | 82726 | | BioAssay type | Literature | | Target | | | PubMed | 12166940 | | Data Table |  |
|
| 4 | [SID103349923] | Unspecified | ED50 | 1000 | Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells [AID106907, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | ED50 | 1000 [uM] | | BioAssay | Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells | | AID | 106907 | | BioAssay type | Literature | | Target | | | PubMed | 9986720 | | Data Table |  |
|
| 5 | [SID103349923] | Unspecified | | | Inhibition of Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration reaction at a concentration of 25 uM [AID91578, Type: Literature] | Integrase [gi:82312013] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | BioAssay | Inhibition of Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration reaction at a concentration of 25 uM | | AID | 91578 | | BioAssay type | Literature | | Target | Integrase [gi:82312013] | | PubMed | 9986720 | | Data Table |  |
|
| 6 | [SID103349923] | Unspecified | | | Therapeutic index (ratio of CT5 to ED50). [AID235210, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | BioAssay | Therapeutic index (ratio of CT5 to ED50). | | AID | 235210 | | BioAssay type | Literature | | Target | | | PubMed | 12166940 | | Data Table |  |
|
| 7 | [SID103349923] | Unspecified | | | Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5% [AID104233, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | BioAssay | Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5% | | AID | 104233 | | BioAssay type | Literature | | Target | | | PubMed | 9986720 | | Data Table |  |
|
| 8 | [SID103349923] | Unspecified | | | Inhibition of MT-2 cell growth by 5% or less over a 72 hr time period. [AID106733, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103349923 | | CID | 875 | | Outcome | Unspecified | | BioAssay | Inhibition of MT-2 cell growth by 5% or less over a 72 hr time period. | | AID | 106733 | | BioAssay type | Literature | | Target | | | PubMed | 12166940 | | Data Table |  |
|
| 9 | [SID10319598] | Inactive | | | HERG Channel Activity [AID376, Type: other] | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 10319598 | | CID | 875 | | Outcome | Inactive | | BioAssay | HERG Channel Activity | | AID | 376 | | BioAssay type | other | | Target | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] | | PubMed | | | Data Table |  |
|
| 10 | [SID10319598] | Inactive | | | HERG Channel Activity [AID376, Type: other] | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 10319598 | | CID | 875 | | Outcome | Inactive | | BioAssay | HERG Channel Activity | | AID | 376 | | BioAssay type | other | | Target | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] | | PubMed | | | Data Table |  |
|
| 11 | [SID10319598] | Inactive | | | HERG Channel Activity [AID376, Type: other] | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 10319598 | | CID | 875 | | Outcome | Inactive | | BioAssay | HERG Channel Activity | | AID | 376 | | BioAssay type | other | | Target | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] | | PubMed | | | Data Table |  |
|
| 12 | [SID10319598] | Inactive | | | HERG Channel Activity [AID376, Type: other] | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 10319598 | | CID | 875 | | Outcome | Inactive | | BioAssay | HERG Channel Activity | | AID | 376 | | BioAssay type | other | | Target | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] | | PubMed | | | Data Table |  |
|
| 13 | [SID10319598] | Inactive | | | HERG Channel Activity [AID376, Type: other] | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 10319598 | | CID | 875 | | Outcome | Inactive | | BioAssay | HERG Channel Activity | | AID | 376 | | BioAssay type | other | | Target | potassium voltage-gated channel subfamily H member 2 isoform a [Homo sapiens] [gi:4557729] | | PubMed | | | Data Table |  |
|
| 14 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID109777] | Inactive | | | NCI AIDS Antiviral Assay [AID179, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI AIDS Antiviral Assay | | AID | 179 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID109777] | Inactive | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 109777 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID430469] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID256, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 430469 | | CID | 875 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 256 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|